{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:31:53Z","timestamp":1788827513803,"version":"build-2803163510"},"reference-count":95,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a multisystem auto-immune disease that may affect any organ\/system, including the cardiovascular system. Several studies have shown that SLE is associated with an increased risk of cardiovascular disease (CVD), even though most of the patients who have lupus are young women. In this review, we present that apart from the traditional risk factors, there are more appropriate SLE-related indices such as imaging parameters, auto-antibodies, disease manifestations, medications, and genetic factors that might represent useful tools to create an algorithm for early identification of SLE patients at increased risk of CVD. Early recognition and appropriate treatment of patients at increased CVD risk might reduce morbidity\/mortality and improve the quality of life of patients with SLE.<\/jats:p>","DOI":"10.3390\/jcm14145085","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T14:13:43Z","timestamp":1752761623000},"page":"5085","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combining Laboratory and Imaging Evaluation for Cardiovascular Risk Stratification in Systemic Lupus Erythematosus"],"prefix":"10.3390","volume":"14","author":[{"given":"Chrysanthi","family":"Staveri","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, GR 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Vartela","sequence":"additional","affiliation":[{"name":"Onassis Cardiac Surgery Center, GR 17674 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1089-7766","authenticated-orcid":false,"given":"Sophie I.","family":"Mavrogeni","sequence":"additional","affiliation":[{"name":"University Research Institute of Maternal and Child Health, National and Kapodistrian University of Athens School of Medicine, Aghia Sophia Children\u2019s Hospital, GR 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-8083","authenticated-orcid":false,"given":"Stamatis-Nick C.","family":"Liossis","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, GR 26504 Patras, Greece"},{"name":"Division of Rheumatology, Department of Internal Medicine, University of Patras School of Medicine, GR 26500 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rdc.2013.10.003","article-title":"Cardiac manifestations of systemic lupus erythematosus","volume":"40","author":"Miner","year":"2014","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_2","first-page":"e39284","article-title":"Systemic Lupus Erythematosus and Cardiovascular Diseases: A Systematic Review","volume":"15","author":"Nor","year":"2023","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1573397113666170704102444","article-title":"Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus","volume":"13","author":"Tselios","year":"2017","journal-title":"Curr. Rheumatol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e000221","DOI":"10.1136\/lupus-2017-000221","article-title":"Associates and predictors of pleurisy or pericarditis in SLE","volume":"4","author":"Ryu","year":"2017","journal-title":"Lupus Sci. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"iv8","DOI":"10.1093\/rheumatology\/kel308","article-title":"Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus","volume":"45","author":"Tincani","year":"2006","journal-title":"Rheumatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/0961203315625460","article-title":"Chinese SLE Treatment and Research group (CSTAR) registry VII: Prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus","volume":"25","author":"Zhao","year":"2016","journal-title":"Lupus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4065\/74.3.275","article-title":"Cardiac involvement in systemic lupus erythematosus","volume":"74","author":"Moder","year":"1999","journal-title":"Mayo Clin. Proc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00296-009-1087-0","article-title":"Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1790 cases","volume":"30","author":"Feng","year":"2010","journal-title":"Rheumatol. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3899\/jrheum.090249","article-title":"Clinical and serologic factors associated with lupus pleuritis","volume":"37","author":"Mittoo","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MD.0b013e3181cb449c","article-title":"Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus: A retrospective review of 917 patients in South China","volume":"89","author":"Tang","year":"2010","journal-title":"Medicine"},{"key":"ref_12","first-page":"469","article-title":"Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus","volume":"17","author":"Yasuma","year":"1990","journal-title":"J. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3899\/jrheum.080588","article-title":"Autoantibodies in pediatric systemic lupus erythematosus: Ethnic grouping, cluster analysis, and clinical correlations","volume":"36","author":"Fritzler","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","article-title":"Cardiac involvement in systemic lupus erythematosus","volume":"14","author":"Doria","year":"2005","journal-title":"Lupus"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/art.1780351115","article-title":"The spectrum of pericardial tamponade in systemic lupus erythematosus. Report of ten patients","volume":"35","author":"Kahl","year":"1992","journal-title":"Arthritis Rheum."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0961203308100659","article-title":"The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: A retrospective study and literature review","volume":"18","author":"Rosenbaum","year":"2009","journal-title":"Lupus"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.108.844753","article-title":"Controversial issues in the management of pericardial diseases","volume":"121","author":"Imazio","year":"2010","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01451283","article-title":"A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value","volume":"17","author":"Jacobsen","year":"1998","journal-title":"Clin. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1191\/0961203305lu2228oa","article-title":"Acute lupus myocarditis: Clinical features and outcome of an oriental case series","volume":"14","author":"Law","year":"2005","journal-title":"Lupus"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9343(02)01223-8","article-title":"Myocarditis in systemic lupus erythematosus","volume":"113","author":"Wijetunga","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ashour, A.A., Mansour, S., Talal Basrak, M., Altermanini, M., Sawaf, B., Atta, M.A., and Habib, M.B. (2023). Case report: Severe sinus tachycardia as a leading manifestation of systemic lupus erythematosus flare. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1277285"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/kem371","article-title":"Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV)","volume":"47","author":"Apte","year":"2008","journal-title":"Rheumatology"},{"key":"ref_23","first-page":"e33449","article-title":"Coronary Artery Disease in Systemic Lupus Erythematosus: What Do the Facts Say?","volume":"15","author":"Baeza","year":"2023","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/acr.21782","article-title":"Association of systemic lupus erythematosus with angiographically defined coronary artery disease: A retrospective cohort study","volume":"65","author":"Kaul","year":"2013","journal-title":"Arthritis Care Res."},{"key":"ref_25","unstructured":"Feingold, K.R., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Hofland, J., and Kalra, S. (2000). The Effect of Inflammation and Infection on Lipids and Lipoproteins. Endotext, MDText.com, Inc."},{"key":"ref_26","first-page":"e43061","article-title":"Spontaneous Coronary Artery Disease (SCAD) in a Patient With Systemic Lupus Erythematosus (SLE)","volume":"15","author":"Patel","year":"2023","journal-title":"Cureus"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e018555","DOI":"10.1161\/JAHA.120.018555","article-title":"Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus","volume":"10","author":"Weber","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/acr.23920","article-title":"Five-Year Follow-Up of Coronary Microvascular Dysfunction and Coronary Artery Disease in Systemic Lupus Erythematosus: Results From a Community-Based Lupus Cohort","volume":"72","author":"Sandhu","year":"2020","journal-title":"Arthritis Care Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcmg.2010.09.019","article-title":"Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus","volume":"4","author":"Ishimori","year":"2011","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00393-018-0555-x","article-title":"Aortic aneurysm and dissection in systemic lupus erythematosus","volume":"78","author":"Yuan","year":"2019","journal-title":"Z. Rheumatol."},{"key":"ref_31","first-page":"373","article-title":"Echocardiographic characteristics of cardiac involvement in Systemic lupus erythematosus","volume":"97","author":"Drissa","year":"2019","journal-title":"Tunis. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.15171\/jcvtr.2018.40","article-title":"Early diagnosis of cardiac involvement in systemic lupus erythematosus via global longitudinal strain (GLS) by speckle tracking echocardiography","volume":"10","author":"Nikdoust","year":"2018","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.21037\/qims-20-859","article-title":"Layer-specific strain and dyssynchrony index alteration in new-onset systemic lupus erythematosus patients without cardiac symptoms","volume":"11","author":"Luo","year":"2021","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejim.2019.12.033","article-title":"Speckle tracking echocardiography in patients with systemic lupus erythematosus: A meta-analysis","volume":"73","author":"Forte","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_35","first-page":"e47157","article-title":"Computed Tomography (CT) Calcium Scoring in Primary Prevention of Acute Coronary Syndrome and Future Cardiac Events in Patients With Systemic Lupus Erythematosus","volume":"15","author":"Wu","year":"2023","journal-title":"Cureus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00296-016-3615-z","article-title":"Progression of noncalcified and calcified coronary plaque by CT angiography in SLE","volume":"37","author":"Khan","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejim.2022.04.001","article-title":"Asymptomatic coronary artery disease assessed by coronary computed tomography in patients with systemic lupus erythematosus: A systematic review and meta-analysis","volume":"100","author":"Cervera","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MCA.0000000000001205","article-title":"Coronary plaque progression is greater in systemic lupus erythematosus than rheumatoid arthritis","volume":"34","author":"Moore","year":"2023","journal-title":"Coron. Artery Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejrad.2019.02.012","article-title":"Coronary CT angiography radiation dose trends: A 10-year analysis to develop institutional diagnostic reference levels","volume":"113","author":"Lin","year":"2019","journal-title":"Eur. J. Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","article-title":"Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study","volume":"49","author":"Pijls","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study","volume":"56","author":"Pijls","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"Pijls","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1408758","article-title":"Fractional flow reserve-guided PCI for stable coronary artery disease","volume":"371","author":"Fearon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force Members, Windecker, S., Kolh, P., Alfonso, F., Collet, J.P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., and Head, S.J. (2014). 2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Hear. J., 35, 2541\u20132619.","DOI":"10.1093\/eurheartj\/ehu278"},{"key":"ref_45","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2008.07.031","article-title":"Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: Results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial","volume":"52","author":"Budoff","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2008.08.058","article-title":"Diagnostic accuracy of 64-slice computed tomography coronary angiography: A prospective, multicenter, multivendor study","volume":"52","author":"Meijboom","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa0806576","article-title":"Diagnostic performance of coronary angiography by 64-row CT","volume":"359","author":"Miller","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.jacc.2009.11.096","article-title":"Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation","volume":"55","author":"Tonino","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2007.03.067","article-title":"Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality","volume":"50","author":"Min","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","article-title":"Age-and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease","volume":"58","author":"Min","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_52","first-page":"269","article-title":"Noninvasive FFR derived from coronary CT angiography in the management of coronary artery disease: Technology and clinical update","volume":"12","author":"Nakanishi","year":"2016","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2478\/prilozi-2018-0045","article-title":"Myocardial Perfusion Abnormalities in Young and Premenopausal Women with Systemic Lupus Erythematosus, Detected with 99MTC MIBI Myocardial Perfusion Scintigraphy\u2014Prevalence and Correlation with Proatherogenic Factors","volume":"39","author":"Sandevska","year":"2018","journal-title":"Prilozi"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11883-023-01107-0","article-title":"The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations","volume":"25","author":"Nayfeh","year":"2023","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Mavrogeni, S.I., Markousis-Mavrogenis, G., Karapanagiotou, O., Toutouzas, K., Argyriou, P., Velitsista, S., Kanoupakis, G., Apostolou, D., Hautemann, D., and Sfikakis, P.P. (2019). Silent Myocardial Perfusion Abnormalities Detected by Stress Cardiovascular Magnetic Resonance in Antiphospholipid Syndrome: A Case-Control Study. J. Clin. Med., 8.","DOI":"10.3390\/jcm8071084"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Burkard, T., Trendelenburg, M., Daikeler, T., Hess, C., Bremerich, J., Haaf, P., Buser, P., and Zellweger, M.J. (2018). The heart in systemic lupus erythematosus\u2014A comprehensive approach by cardiovascular magnetic resonance tomography. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202105"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0961203317731533","article-title":"Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus","volume":"27","author":"Mavrogeni","year":"2018","journal-title":"Lupus"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203312462265","article-title":"The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis","volume":"22","author":"Mavrogeni","year":"2013","journal-title":"Lupus"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2017.01.104","article-title":"Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment na\u00efve patients with connective tissue diseases","volume":"236","author":"Mavrogeni","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10554-014-0560-3","article-title":"Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus","volume":"31","author":"Zhang","year":"2015","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCGENETICS.113.000044","article-title":"Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants","volume":"6","author":"Leonard","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/annrheumdis-2017-212614","article-title":"Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis","volume":"77","author":"Leonard","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/annrheumdis-2012-201760","article-title":"HLA-DRB1*04\/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus","volume":"72","author":"Gustafsson","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Liu, C., Zhou, Y., Zhou, Y., Tang, X., Tang, L., and Wang, J. (2023). Identification of crucial genes for predicting the risk of atherosclerosis with system lupus erythematosus based on comprehensive bioinformatics analysis and machine learning. Comput. Biol. Med., 152.","DOI":"10.1016\/j.compbiomed.2022.106388"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gao, N., Kong, M., Li, X., Wei, D., Zhu, X., Hong, Z., Hong, Z., Ni, M., Wang, Y., and Dong, A. (2022). Systemic Lupus Erythematosus and Cardiovascular Disease: A Mendelian Randomization Study. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.908831"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"100805","DOI":"10.1016\/j.xcrm.2022.100805","article-title":"Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease","volume":"3","author":"Kain","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Huang, S., Huang, F., Mei, C., Tian, F., Fan, Y., and Bao, J. (2022). Systemic lupus erythematosus and the risk of cardiovascular diseases: A two-sample Mendelian randomization study. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.896499"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2009.115535","article-title":"A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus","volume":"69","author":"Svenungsson","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa033122","article-title":"Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus","volume":"351","author":"Garred","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/rheumatology\/keh613","article-title":"Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: Association between C-reactive protein (CRP) gene polymorphisms and vascular events","volume":"44","author":"Szalai","year":"2005","journal-title":"Rheumatology"},{"key":"ref_71","first-page":"1084","article-title":"The Impact of Antiphospholipid Antibodies on Future Atherosclerotic Cardiovascular Disease Risk in Systemic Lupus Erythematosus","volume":"75","author":"Ding","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/art.43097","article-title":"Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10-Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS Remission","volume":"77","author":"Papazoglou","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/rheumatology\/keac596","article-title":"Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events","volume":"62","author":"Farina","year":"2023","journal-title":"Rheumatology"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Huang, C., Ding, Y., Chen, Z., Wu, L., Wei, W., Zhao, C., Yang, M., Lin, S., Wang, Q., and Tian, X. (2025). Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): The effect of different antiphospholipid antibodies isotypes. BMC Med., 23.","DOI":"10.1186\/s12916-024-03843-9"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijcard.2022.06.040","article-title":"Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head","volume":"363","author":"Barinotti","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Nagy, N., B\u00f3i, B., Papp, G., Fi\u00e1k, E., G\u00e1sp\u00e1r-Kiss, E., Perge, B., Farmasi, N., and Tarr, T. (2024). Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030530"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/ATVBAHA.121.315928","article-title":"Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation","volume":"41","author":"Espinosa","year":"2021","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/ard.49.8.627","article-title":"Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus","volume":"49","author":"Logar","year":"1990","journal-title":"Ann. Rheum. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Cao, R., Lv, H., Tang, B., and Lu, Y. (2025). Anti-Ro\/SSA antibodies in adult arrhythmias: Pathogenesis, clinical implications, and therapeutic strategies. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1561061"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1177\/09612033211027928","article-title":"Usefulness of cardiac screening in patients with systemic lupus erythematosus and anti-Ro\/SSA antibodies","volume":"30","author":"Villuendas","year":"2021","journal-title":"Lupus"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e000267","DOI":"10.1136\/lupus-2018-000267","article-title":"Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: The role of classic and SLE-related factors","volume":"5","author":"Haque","year":"2018","journal-title":"Lupus Sci. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/2047487314546826","article-title":"Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis","volume":"22","author":"Ballocca","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1007\/s10067-023-06608-6","article-title":"Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: An umbrella review","volume":"42","author":"Katayama","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"107466","DOI":"10.1016\/j.intimp.2021.107466","article-title":"Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and Meta-analysis","volume":"94","author":"Lu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/acr2.1035","article-title":"Association of Lupus Nephritis With Coronary Artery Disease by ISN\/RPS Classification: Results From a Large Real-world Lupus Population","volume":"1","author":"Sun","year":"2019","journal-title":"ACR Open Rheumatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.40174","article-title":"Race\/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus","volume":"69","author":"Barbhaiya","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3899\/jrheum.220279","article-title":"Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities","volume":"50","author":"Garg","year":"2023","journal-title":"J. Rheumatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/aje\/kws130","article-title":"Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus","volume":"176","author":"Magder","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08923973.2013.780078","article-title":"Chloroquine cardiomyopathy\u2014A review of the literature","volume":"35","author":"Kandolf","year":"2013","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e2432190","DOI":"10.1001\/jamanetworkopen.2024.32190","article-title":"Hydroxychloroquine and Cardiovascular Events in Patients With Systemic Lupus Erythematosus","volume":"7","author":"Grimaldi","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1093\/rheumatology\/keaa862","article-title":"Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications","volume":"60","author":"Choi","year":"2021","journal-title":"Rheumatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/rheumatology\/keae192","article-title":"Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment","volume":"64","author":"Dedemadi","year":"2025","journal-title":"Rheumatology"},{"key":"ref_93","first-page":"15","article-title":"Risk factors in cardiovascular disease in systemic lupus erythematosus","volume":"9","author":"Sinicato","year":"2013","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/acr.21841","article-title":"High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus","volume":"65","author":"Mok","year":"2013","journal-title":"Arthritis Care Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/ITT.S377076","article-title":"Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician","volume":"12","author":"Semalulu","year":"2023","journal-title":"ImmunoTargets Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/14\/5085\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:11:33Z","timestamp":1760033493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/14\/5085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":95,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["jcm14145085"],"URL":"https:\/\/doi.org\/10.3390\/jcm14145085","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]}}}